Optimal cytoreduction in stage IV ovarian carcinoma -: In reply

被引：0
|
作者：
Bonnefoi, H [1 ]
Gore, ME
机构：
[1] Univ Hosp Geneva, Geneva, Switzerland
[2] Royal Marsden Hosp, London SW3 6JJ, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1999年 / 17卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3004 / 3004
页数：1
相关论文
共 50 条
  • [41] PREOPERATIVE LYMPHOCYTE-MONOCYTE RATIO IS A PREDICTOR OF SUBOPTIMAL CYTOREDUCTION IN STAGE III-IV EPITHELIAL OVARIAN CANCER
    Bae, K. Hong
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1523 - 1523
  • [42] The use of molecular markers to predict for optimal cytoreduction in ovarian cancer
    Fuh, K.
    Kiet, T. K.
    Chen, L.
    Brooks, R. A.
    Sherman, A. E.
    Kapp, D. S.
    Chan, J. K.
    GYNECOLOGIC ONCOLOGY, 2011, 123 (02) : 436 - 437
  • [43] PREOPERATIVE AND LAPAROSCOPIC EVALUATION FOR OPTIMAL CYTOREDUCTION IN ADVANCED OVARIAN CANCER
    Fagotti, A.
    Vizzielli, G.
    Tortorella, L.
    Fanfani, F.
    Costantini, B.
    Ferrandina, G.
    Gallotta, V.
    Alletti, S. Gueli
    Iodice, R.
    Scambia, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [44] Pancreatoduodenectomy as Part of Primary Cytoreduction for Advanced Stage Ovarian Cancer
    Brasoveanu, Vladsilav
    Bacalbasa, Nicolae
    Balescu, Irina
    Tomescu, Dana
    Dima, Simona
    Orban, Carmen
    Vilcu, Mihaela
    Brezean, Iulian
    PROCEEDINGS OF THE 4TH CONGRESS OF THE ROMANIAN SOCIETY FOR MINIMAL INVASIVE SURGERY IN GINECOLOGY / ANNUAL DAYS OF THE NATIONAL INSTITUTE FOR MOTHER AND CHILD HEALTH ALESSANDRESCU-RUSESCU, 2019, : 60 - 63
  • [45] Radical surgery versus standard surgery for primary cytoreduction of bulky stage IIIC and IV ovarian cancer: an observational study
    Yulan Ren
    Rong Jiang
    Sheng Yin
    Chao You
    Dongli Liu
    Xi Cheng
    Jie Tang
    Rongyu Zang
    BMC Cancer, 15
  • [46] Radical surgery versus standard surgery for primary cytoreduction of bulky stage IIIC and IV ovarian cancer: an observational study
    Ren, Yulan
    Jiang, Rong
    Yin, Sheng
    You, Chao
    Liu, Dongli
    Cheng, Xi
    Tang, Jie
    Zang, Rongyu
    BMC CANCER, 2015, 15
  • [47] The use of molecular markers to predict for optimal cytoreduction in ovarian cancer
    Fuh, K.
    Kiet, T.
    Chen, L.
    Sherman, A.
    Kapp, D.
    Chan, J.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S13 - S13
  • [48] Preoperative Lymphocyte-Monocyte Ratio Is a Predictor of Suboptimal Cytoreduction in Stage III-IV Epithelial Ovarian Cancer
    Eo, Wankyu
    Kim, Hong-Bae
    Lee, Yong Joo
    Suh, Dong Soo
    Kim, Ki Hyung
    Kim, Heungyeol
    JOURNAL OF CANCER, 2016, 7 (13): : 1772 - 1779
  • [49] Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays - Discussion
    Berek, JS
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (04) : 922 - 924
  • [50] SURGICAL CYTOREDUCTION IN ADVANCED STAGE SEROUS ENDOMETRIAL CARCINOMA
    Nobre, S. Pedra
    Zhou, Q.
    Iasonos, A.
    Chi, D.
    Makker, V.
    Abu-Rustum, N.
    Leitao, M.
    Mueller, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A18 - A19
12345